|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,268.00 GBX | +0.52% |
|
-2.70% | -3.81% |
| 09:21am | ASTRAZENECA : Gets a Buy rating from Jefferies | ZD |
| 06-15 | UK Shares End Lower as Investors Assess US-Iran Peace Framework | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 275B | |||||
| 1,007B | |||||
| 567B | |||||
| 392B | |||||
| 328B | |||||
| 277B |
- Stock Market
- Stocks
- AZN Stock
- Charts AstraZeneca PLC
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition